PsychNostics, LLC
Baltimore, MD, US· latest recorded location
PsychNostics, LLC is named on 5 US grants and 8 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 5
- Published applications
- 8
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 30 Jul 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 2 | 3 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Technology areas
Share of 13 documents
- G01NInvestigating or analysing materials by determining their chemical or physical properties10
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5
- C12NMicroorganisms or enzymes3
- C40BCombinatorial chemistry3
- A61KMedicines and medical preparations2
- A61PTherapeutic uses of medicines1
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the1
Recent patents
- Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder30 Jul 2019US 10,365,268 B2
- Genes expressed in mental illness and mood disorders28 May 2019US 10,301,615 B2
- Methods for treating ADHD and bipolar disorder using a membrane potential ratio test25 Sep 2018US 10,082,498 B2
- Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder20 Dec 2016US 9,523,673 B2
- Methods for diagnosing an attention-deficit/Hyperactivity disorder15 Mar 2011US 7,906,300 B2
- Combination therapies for treating bipolar disorder and adhd, and methods for using the same1 Jul 2021US 2021/0196697 A1
- Genes expressed in mental illness and mood disorders10 Oct 2019US 2019/0309285 A1
- Combination therapies for treating bipolar disorder, and methods for using the same3 Oct 2019US 2019/0302102 A1
- Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder26 Sep 2019US 2019/0293633 A1
- Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder12 Jan 2017US 2017/0010255 A1
Most cited
By later US patents